CORTICOSTEROID CONTAINING ORALLY DISINTEGRATING TABLET COMPOSITIONS FOR EOSINOPHILIC ESOPHAGITIS

The present invention is directed to orally administered compositions of topically acting corticosteroids for the treatment of inflammation of the gastrointestinal tracts such as eosinophilic esophagitis. The present invention also provides a method for treating conditions associated with inflammati...

Full description

Saved in:
Bibliographic Details
Main Authors VENKATESH, GOPI M, LAI, JIN-WANG, GOSSELIN, MICHAEL A
Format Patent
LanguageEnglish
Polish
Published 30.04.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention is directed to orally administered compositions of topically acting corticosteroids for the treatment of inflammation of the gastrointestinal tracts such as eosinophilic esophagitis. The present invention also provides a method for treating conditions associated with inflammation of the gastrointestinal tract in an individual. The method comprises administering to an individual in need thereof a pharmaceutical composition of the present invention as orally disintegrating tablets comprising a topically active corticosteroid adsorbed onto a pharmaceutically acceptable carrier such as silicified microcrystalline cellulose.
AbstractList The present invention is directed to orally administered compositions of topically acting corticosteroids for the treatment of inflammation of the gastrointestinal tracts such as eosinophilic esophagitis. The present invention also provides a method for treating conditions associated with inflammation of the gastrointestinal tract in an individual. The method comprises administering to an individual in need thereof a pharmaceutical composition of the present invention as orally disintegrating tablets comprising a topically active corticosteroid adsorbed onto a pharmaceutically acceptable carrier such as silicified microcrystalline cellulose.
Author VENKATESH, GOPI M
LAI, JIN-WANG
GOSSELIN, MICHAEL A
Author_xml – fullname: VENKATESH, GOPI M
– fullname: LAI, JIN-WANG
– fullname: GOSSELIN, MICHAEL A
BookMark eNqNik0KwjAUhLPQhX93iAcQlJS6jmmaPoh5IXkbV7VIXElaqPfHCB7A1cx8863ZIo85rdhdYSBQGEkHhIYrdCTBgTMcg7T2xhuI4EibIOlLSV6spuJdPUYgQBd5i4Hrshz6DiwormNp0pQ7btnyObzmtPvlhu1bTao7pGns0zwNj5TTu_dWHKtTda6JhPjH-QBaMDaX
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate Kortykosteroidy zawierające ulegające rozpadowi w jamie ustnej kompozycje tabletek dla eozynofilowego zapalenia przełyku
ExternalDocumentID PL3041476TT3
GroupedDBID EVB
ID FETCH-epo_espacenet_PL3041476TT33
IEDL.DBID EVB
IngestDate Fri Jul 19 12:49:42 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Polish
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_PL3041476TT33
Notes Application Number: PL20140842811T
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200430&DB=EPODOC&CC=PL&NR=3041476T3
ParticipantIDs epo_espacenet_PL3041476TT3
PublicationCentury 2000
PublicationDate 20200430
PublicationDateYYYYMMDD 2020-04-30
PublicationDate_xml – month: 04
  year: 2020
  text: 20200430
  day: 30
PublicationDecade 2020
PublicationYear 2020
RelatedCompanies Adare Pharmaceuticals US, L.P
RelatedCompanies_xml – name: Adare Pharmaceuticals US, L.P
Score 3.2659378
Snippet The present invention is directed to orally administered compositions of topically acting corticosteroids for the treatment of inflammation of the...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title CORTICOSTEROID CONTAINING ORALLY DISINTEGRATING TABLET COMPOSITIONS FOR EOSINOPHILIC ESOPHAGITIS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200430&DB=EPODOC&locale=&CC=PL&NR=3041476T3
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8Mw8JhT1Dedis4PKkjfit36tT4U6dJui3RNWaPMp7m0FQayDVfx73upm_qib5cPQu7C5b5yF4AbR-h2ppu5hrqAjQaKo2uunlmayDtuXrhmoRfSDzmM7cGDeT-2xjWYbXJhqjqhH1VxROSoDPm9rO7r5Y8TK6jeVq5uxQy7Fnc97gXq2jpuVyWs1KDrhQkLGFEJ8ZJIjUceWu0t07G5sQXbqEU7khnCx65MSln-lii9A9hJcLF5eQi15WsD9sjm47UG7A7X8W4E16y3OoJnwkacEpai_slooBAWc5_GNO4rbORH0ZMS0FQWuO1LtxP2cr8bhRznDROW0ipbWEGTTwmxFbNkQCNKlDBFyO_jcHoM172Qk4GGW518k2WSRBukuGGcQH2-mBenoNh4LHors3JLZKYQbXfqdFoyPCimiLb5cgbNv9dp_jd4DvuSxF-xlAuol2_vxSWK5FJcVcT8BGV6iYY
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dT4Mw8DKncb7p1Oj8wsTwRmQbH-OBGFbYqAIloxp9mitgssRsi8P49z1wU1_07XrXNO01195H7wpwZQrVSFUtU1AXMNBAMVXFUlNdEVnPynJLy9W89EOGkeHfa7eP-mMNputcmKpO6EdVHBElKkV5L6rzevHjxHKrt5XLazFF1PxmwG1XXlnHnaqElez2bS9mLiMyIXYcyNHIRqu9rZkG727AJmrYZikM3kO_TEpZ_L5RBruwFeNgs2IPaovXJjTI-uO1JmyHq3g3givRW-7DM2EjTglLUP9k1JUIi7hDIxoNJTZyguBJcmlSFrgdlm4nxHKnH3gc-4UxS2iVLSyhySd52IpY7NOAEslLEHKGSE4O4HLgceIrONXxN1vGcbBeFO92D6E-m8_yI5AM3Ba1neqZLlJNiI41MXvtMjwoJrgd2ssxtP4ep_Uf8QIaPg-DcUCjuxPYKdn9FVc5hXrx9p6f4fVciPOKsZ8Fqox5
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=CORTICOSTEROID+CONTAINING+ORALLY+DISINTEGRATING+TABLET+COMPOSITIONS+FOR+EOSINOPHILIC+ESOPHAGITIS&rft.inventor=VENKATESH%2C+GOPI+M&rft.inventor=LAI%2C+JIN-WANG&rft.inventor=GOSSELIN%2C+MICHAEL+A&rft.date=2020-04-30&rft.externalDBID=T3&rft.externalDocID=PL3041476TT3